SCHEMBL20139276

SCHEMBL20139276

O=C(O)N1CCCN(c2ccccc2Cl)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.57
GRM5 P41594 1/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 1/20 0.51
HTR7 P34969 1/20 0.51
MAPK1 P28482 2/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HTR1A P08908 1/20 0.50
GAA P10253 2/20 0.49
ALDH1A1 P00352 1/20 0.49
GLA P06280 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
DRD2 P14416 1/20 0.49
DRD4 P21917 1/20 0.49
DRD3 P35462 1/20 0.49
NOTUM Q6P988 1/20 0.49
RBP4 P02753 1/20 0.48
KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2857040 0.93 AKR1C3 (0.64) AKR1C3GRM5MEN1KMT2AMAPT
SCHEMBL27486756 0.83 AKR1C3 (0.74) AKR1C3GRM5MEN1KMT2AMAPT
SCHEMBL16586727 0.83 TSHR (0.59) AKR1C3MEN1KMT2AALDH1A1LMNA
SCHEMBL27237946 0.82 DRD2 (0.60) AKR1C3DRD2DRD4DRD3NOTUM
SCHEMBL3709763 0.81 SCD5 (0.54) AKR1C3GRM5MEN1KMT2AMAPT
SCHEMBL30407939 0.80 ADRB1 (0.65) AKR1C3MAPTMAPK1RAB9AHTR1A
SCHEMBL5235579 0.80 MEN1 (0.59) AKR1C3MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17276412 0.80 AKR1C3 (0.64) AKR1C3GRM5MEN1KMT2AMAPT
SCHEMBL1491206 0.80 KMT2A (0.64) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL27237926 0.79 AKR1C3 (0.49) AKR1C3GRM5MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089493-A1 PYRROLE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed